Honma, N., Inoue, T., Tsuchiya, N., Koizumi, A., Yamamoto, R., Nara, T., . . . Habuchi, T. (2020). Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib. Health Sci Rep.
Citação norma ChicagoHonma, Naoko, et al. "Prognostic Value of Plasminogen Activator Inhibitor‐1 in Biomarker Exploration Using Multiplex Immunoassay in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib." Health Sci Rep 2020.
MLA citiranjeHonma, Naoko, et al. "Prognostic Value of Plasminogen Activator Inhibitor‐1 in Biomarker Exploration Using Multiplex Immunoassay in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib." Health Sci Rep 2020.